CNS.L $6.65 0%
2172.HK $12.94 -0.3082%
WEJOW $0.03 -2.0306%
LQGH.L $4.33 -0.2535%
MATE.L $94.53 0.0317%
0KXS.L $136.28 0.6697%
EJFZ.L $130.50 0%
CNF $3.16 9.6081%
3333.HK $1.65 0%
0924.HK $0.73 2.8169%
FME.L $3.09 1.3115%
5UX.SI $0.14 0%
0096.HK $0.67 13.5593%
0981.HK $20.20 0.2481%
0QZA.L $99.24 0.0106%
ADC-PA $17.99 0.5022%
SUSA $86.73 -0.5162%
JCOM $142.84 0%
CRYP $16.27 -1.5461%
CAI $56.00 0%
CHPM $10.18 0%
OTLY $2.08 -2.1226%
RADI $14.73 -0.0339%
INDY $42.67 -0.0937%
0882.HK $1.70 0%
HBIO $5.66 -1.3089%
DS $0.17 -59.1319%
LMFA $0.74 1.3699%
DNO $46.08 0%
1420.HK $0.10 1.0526%
ALRPD.PA $0.00 0%
NTGR $13.76 -0.1814%
MSON $26.54 0%
DXR $11.60 -8.5894%
1183.HK $1.58 -1.8634%
HART $28.69 0.1942%
GGAA $10.70 1.0359%
EW $88.73 -0.062%
QUED.PA $122.64 0.1961%
GLIN $33.48 -0.0149%
ASPL.L $0.14 0%
AVNT $38.26 -0.9707%
DMS $0.60 1.6949%
QRHC $5.40 0.7463%
ABVX.PA $18.26 12.716%
0913.HK $0.49 -14.0351%
IRAAW $0.07 0%
8019.HK $0.25 0%
ZEN.BR $220.00 0%
PSN.L $1 337.50 2.569%
AIT $128.88 1.1935%
CARB.L $31.58 -0.2369%
MAP.MC $1.86 0.9772%
CODI $20.11 2.185%
0K7X.L $10.86 -6.5002%
CURE $99.09 -1.5304%
AXLA $0.42 6.1421%
0296.HK $0.56 0%
MLBSP.PA $3.78 0%
JMPNZ $25.33 0%
8418.HK $0.91 -1.087%
0919.HK $0.15 2.0408%
1113.HK $45.60 -1.8299%
SOFT.L $3.82 0%
SDWD.L $6.93 0.435%
KERNW $0.01 3.5294%
DRH-PA $25.59 0.3136%
CUTR $13.88 -1.8388%
MTE.PA $185.94 0.1454%
0HD0.L $24.83 0.0032%
WIZZ.L $3 009.00 1.041%
GECCL $25.35 0%
QDT.PA $17.48 -0.7946%
LFI.L $39.94 3.7403%
DTEL.BR $21.56 0%
DHBCW $0.00 0%
KBWD $13.89 -1.1224%
0UAI.L $51.60 0%
AGLE $0.16 -1.7699%
BBSE3.SA $33.97 0%
SLRC $13.55 -1.9537%
ASB-PE $15.02 -1.5714%
MEL.NZ $5.50 0.5484%
EZTC3.SA $14.93 -7.3246%
NOC $434.77 -0.2478%
CNGL $10.66 0%
AGIH $24.70 0%
0550.HK $0.29 0%
SLCRU $7.40 0%
NGMS $12.76 -11.3273%
0A05.L $118.38 0.1602%
AJG $216.59 -0.1015%
SAK $25.20 0%
0UAN.L $15.40 1.1363%
ADT1.L $182.80 -5.0883%
1617.HK $0.10 -3.0612%
MICT $0.93 0%
ALTR $67.34 -0.2666%
AGTA.L $1.25 13.6364%
NMT $10.39 -0.1442%
Eng
Логотип
Eng
Лого

JW (Cayman) Therapeutics Co. Ltd 2126.HK

$3.29

-$0.13 (-4.08%)
На 18:03, 12 мая 2023

Ключевые показатели

  • Marketcap

    1393412040.00000000

  • week52high

    9.46

  • week52low

    2.70

  • Revenue

    145702000

  • P/E TTM

    0

  • Beta

    2.02610900

  • EPS

    -2.48000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    29 мар 2023 г. в 11:21

Описание компании

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек